Head-to-head · computed 2026-08-11
MEDVi vs ShedRx
MEDVi: MEDVi advertises a $179 semaglutide start that tiers to $299 at maintenance; tirzepatide is $399 flat. ShedRx: ShedRx advertises accessible entry pricing ($175 semaglutide, $199 tirzepatide) but tiers upward with dose — $249 and $289 respectively at the maintenance basis.
Tirzepatide
| MEDVi | ShedRx | |
|---|---|---|
| All-in maintenance | $399/mo | $289/mo |
| Best plan rate | $399/mo | $289/mo |
| 12-month total | $4,788 | $3,468 |
| Status | Provider-stated · 2026-08-05 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, ShedRx's $289 a month undercuts MEDVi's $399 by $110 a month at the 10 mg/wk maintenance basis — $1,320 across a year. ShedRx's figure is provider-stated (captured 2026-08-05) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
MEDVi's tirzepatide ladder runs $399 a month billed monthly. ShedRx's runs $289 a month billed monthly. On the twelve-month basis ShedRx's $3,468 beats MEDVi's $4,788 by $1,320 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Semaglutide
| MEDVi | ShedRx | |
|---|---|---|
| All-in maintenance | $299/mo | $249/mo |
| Best plan rate | $299/mo | $249/mo |
| 12-month total | $3,588 | $2,988 |
| Status | Provider-stated · 2026-08-05 | Provider-stated · 2026-08-05 |
The arithmetic
On the figures our desk holds, ShedRx's $249 a month undercuts MEDVi's $299 by $50 a month at the 2.4 mg/wk maintenance basis — $600 across a year. ShedRx's figure is provider-stated (captured 2026-08-05) and MEDVi's is provider-stated (captured 2026-08-05); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
MEDVi's semaglutide ladder runs $299 a month billed monthly. ShedRx's runs $249 a month billed monthly. On the twelve-month basis ShedRx's $2,988 beats MEDVi's $3,588 by $600 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On dose economics, MEDVi is dose-flat — the price survives titration — while ShedRx's pricing can move with the dose, a difference that compounds through a standard escalation schedule and matters most to buyers expecting to reach the higher maintenance doses.
Structure, side by side
MEDVi
- MembershipNone
- Dose policyTiered on semaglutide; tirzepatide flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
ShedRx
- MembershipNone
- Dose policyTiered by dose
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
What our desk is watching on each
MEDVi: Start-vs-maintenance spread on semaglutide; compare on maintenance.
ShedRx: Start-vs-maintenance spread is among the widest in the index; budget on the maintenance figure.
Questions people ask
Is MEDVi or ShedRx cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does MEDVi vs ShedRx miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do MEDVi and ShedRx cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $4,788 at MEDVi and $3,468 at ShedRx — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: MEDVi · ShedRx. Official sites: MEDVi ↗ · ShedRx ↗. Nothing here is medical advice.